Key points
- CDC's Advanced Molecular Detection (AMD) program is helping build and integrate the use of genomic sequencing technologies into public health nationwide.
- The cumulative local investment to New York from FY2021-2023 is $15,659,312*.
- New York serves the Northeast region as the Community of Practice Domain Lead.
Total investment: $15,659,312*
*Investments listed above do not include New York City which receives direct financial support through the ELC Cooperative Agreement.
Funding to public health departments includes support from the American Rescue Plan of 2021 and AMD annual appropriations in FY2021-2023.
Implementing AMD technology
The AMD program builds and integrates laboratory, bioinformatics, and epidemiology technologies across CDC and nationwide. Since 2014, AMD has received support from Congress—now a $40 million per year appropriation—to implement these technologies in public health programs. Through investments in AMD technologies, CDC is improving both public health outcomes and preparedness in dozens of areas including foodborne disease, influenza, antibiotic resistance, hepatitis, pneumonia, and meningitis.
With funding from the American Rescue Plan Act of 2021, the AMD program developed a multi-year plan to expand support to state, local, and territorial public health laboratories providing more staff and resources to collect and sequence SARS-CoV-2 specimens, identify and track variants, and share data for public health use.
Workforce development
New York is part of the Northeast region. In 2018, the AMD program established seven workforce development regions across the country. Each region has an AMD training lead and a bioinformatics lead. This provides a network of customized AMD support which helps develop skills and provides training assistance to public health labs across the country.
Through the Northeast region's training resources, New York receives lab support on data analysis and how to interface with IT departments. They also receive both pathogen-specific training and cross-cutting instruction to help staff develop the critical skills necessary to extract, analyze, and interpret sequencing data.
AMD Platform Community of Practice (CoP)
The Office of AMD has established five communities of practice to build processes and tools for relevant interests, concerns, and priorities regarding the AMD Platform. The AMD Platform will serve CDC programs and STLT partners by providing a common infrastructure to perform genomic epidemiology and contribute high-quality data to publicly available data repositories. New York's Domain Leader facilitates collaboration between OAMD and the public health community for the Quality and Standards CoP.